These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

335 related articles for article (PubMed ID: 27264952)

  • 1. miR-411-5p inhibits proliferation and metastasis of breast cancer cell via targeting GRB2.
    Zhang Y; Xu G; Liu G; Ye Y; Zhang C; Fan C; Wang H; Cai H; Xiao R; Huang Z; Luo Q
    Biochem Biophys Res Commun; 2016 Aug; 476(4):607-613. PubMed ID: 27264952
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MiR-98-5p regulates proliferation and metastasis of MCF-7 breast cancer cells by targeting Gab2.
    Shi XY; Wang H; Wang W; Gu YH
    Eur Rev Med Pharmacol Sci; 2019 Apr; 23(7):2847-2855. PubMed ID: 31002135
    [TBL] [Abstract][Full Text] [Related]  

  • 3. miR-424-5p regulates cell proliferation, migration and invasion by targeting doublecortin-like kinase 1 in basal-like breast cancer.
    Wang J; Wang S; Zhou J; Qian Q
    Biomed Pharmacother; 2018 Jun; 102():147-152. PubMed ID: 29550638
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Suppressive role of miR-502-5p in breast cancer via downregulation of TRAF2.
    Sun LL; Wang J; Zhao ZJ; Liu N; Wang AL; Ren HY; Yang F; Diao KX; Fu WN; Wan EH; Mi XY
    Oncol Rep; 2014 May; 31(5):2085-92. PubMed ID: 24677135
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MicroRNA-340 inhibits the migration, invasion, and metastasis of breast cancer cells by targeting Wnt pathway.
    Mohammadi-Yeganeh S; Paryan M; Arefian E; Vasei M; Ghanbarian H; Mahdian R; Karimipoor M; Soleimani M
    Tumour Biol; 2016 Jul; 37(7):8993-9000. PubMed ID: 26758430
    [TBL] [Abstract][Full Text] [Related]  

  • 6. miR-493-5p attenuates the invasiveness and tumorigenicity in human breast cancer by targeting FUT4.
    Zhao L; Feng X; Song X; Zhou H; Zhao Y; Cheng L; Jia L
    Oncol Rep; 2016 Aug; 36(2):1007-15. PubMed ID: 27375041
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MiR-139-5p inhibits the biological function of breast cancer cells by targeting Notch1 and mediates chemosensitivity to docetaxel.
    Zhang HD; Sun DW; Mao L; Zhang J; Jiang LH; Li J; Wu Y; Ji H; Chen W; Wang J; Ma R; Cao HX; Wu JZ; Tang JH
    Biochem Biophys Res Commun; 2015 Oct; 465(4):702-13. PubMed ID: 26299922
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of miR-660-5p expression suppresses tumor development and metastasis in human breast cancer.
    Shen Y; Ye YF; Ruan LW; Bao L; Wu MW; Zhou Y
    Genet Mol Res; 2017 Feb; 16(1):. PubMed ID: 28252173
    [TBL] [Abstract][Full Text] [Related]  

  • 9. miR 1296-5p Inhibits the Migration and Invasion of Gastric Cancer Cells by Repressing ERBB2 Expression.
    Shan X; Wen W; Zhu D; Yan T; Cheng W; Huang Z; Zhang L; Zhang H; Wang T; Zhu W; Zhu Y; Zhu J
    PLoS One; 2017; 12(1):e0170298. PubMed ID: 28099468
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MicroRNA-211-5p suppresses tumour cell proliferation, invasion, migration and metastasis in triple-negative breast cancer by directly targeting SETBP1.
    Chen LL; Zhang ZJ; Yi ZB; Li JJ
    Br J Cancer; 2017 Jun; 117(1):78-88. PubMed ID: 28571042
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vivo and in vitro effects of microRNA-27a on proliferation, migration and invasion of breast cancer cells through targeting of SFRP1 gene via Wnt/β-catenin signaling pathway.
    Kong LY; Xue M; Zhang QC; Su CF
    Oncotarget; 2017 Feb; 8(9):15507-15519. PubMed ID: 28099945
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MiR-361-5p inhibits glycolytic metabolism, proliferation and invasion of breast cancer by targeting FGFR1 and MMP-1.
    Ma F; Zhang L; Ma L; Zhang Y; Zhang J; Guo B
    J Exp Clin Cancer Res; 2017 Nov; 36(1):158. PubMed ID: 29132384
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MiR-142-5p Acts as a Significant Regulator Through Promoting Proliferation, Invasion, and Migration in Breast Cancer Modulated by Targeting SORBS1.
    Yu W; Li D; Zhang Y; Li C; Zhang C; Wang L
    Technol Cancer Res Treat; 2019; 18():1533033819892264. PubMed ID: 31789129
    [TBL] [Abstract][Full Text] [Related]  

  • 14. miR-381 inhibited breast cancer cells proliferation, epithelial-to-mesenchymal transition and metastasis by targeting CXCR4.
    Xue Y; Xu W; Zhao W; Wang W; Zhang D; Wu P
    Biomed Pharmacother; 2017 Feb; 86():426-433. PubMed ID: 28012397
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MicroRNA-383-5p acts as a potential prognostic biomarker and an inhibitor of tumor cell proliferation, migration, and invasion in breast cancer.
    Zhang J; Kong X; Shi Q; Zhao B
    Cancer Biomark; 2020; 27(4):423-432. PubMed ID: 31903982
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MiR-132 prohibits proliferation, invasion, migration, and metastasis in breast cancer by targeting HN1.
    Zhang ZG; Chen WX; Wu YH; Liang HF; Zhang BX
    Biochem Biophys Res Commun; 2014 Nov; 454(1):109-14. PubMed ID: 25450365
    [TBL] [Abstract][Full Text] [Related]  

  • 17. LGR5 acts as a target of miR-340-5p in the suppression of cell progression and drug resistance in breast cancer via Wnt/β-catenin pathway.
    Shi S; Chen X; Liu H; Yu K; Bao Y; Chai J; Gao H; Zou L
    Gene; 2019 Jan; 683():47-53. PubMed ID: 30300682
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MicroRNA-99a-5p suppresses breast cancer progression and cell-cycle pathway through downregulating CDC25A.
    Qin H; Liu W
    J Cell Physiol; 2019 Apr; 234(4):3526-3537. PubMed ID: 30443946
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MiR-204-5p/Six1 feedback loop promotes epithelial-mesenchymal transition in breast cancer.
    Zeng J; Wei M; Shi R; Cai C; Liu X; Li T; Ma W
    Tumour Biol; 2016 Feb; 37(2):2729-35. PubMed ID: 26408179
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MicroRNA-31 controls G protein alpha-13 (GNA13) expression and cell invasion in breast cancer cells.
    Rasheed SA; Teo CR; Beillard EJ; Voorhoeve PM; Zhou W; Ghosh S; Casey PJ
    Mol Cancer; 2015 Mar; 14():67. PubMed ID: 25889182
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.